The rate of interrupted ellipsoid zone after treatment with anti-VEGF for 12 months in the SHE group (67.6%) was significantly higher than that in the type 2 NV (42.2%) and hemorrhage (46.7%) groups. The gene discussed is VEGFA; the disease is sleep-related hypermotor epilepsy.